[ad_1] the candidate vaccine Abdala against the coronavirus, developed by the Center for Genetic Engineering and Biotechnology, has shown a 92.2% efficiency in the first analyzes of the third and final phase …
Read More »[ad_1] the candidate vaccine Abdala against the coronavirus, developed by the Center for Genetic Engineering and Biotechnology, has shown a 92.2% efficiency in the first analyzes of the third and final phase …
Read More »